A complete advanced undergraduate/graduate course with:

Similar documents
A complete advanced undergraduate/graduate course with:

A complete advanced undergraduate/graduate course with:

Renal Cell Carcinoma: Genetics & Imaging Srinivasa R Prasad University of Texas San Antonio

Activation of cellular proto-oncogenes to oncogenes. How was active Ras identified?

Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine

Case Based Urology Learning Program

Kidney Cancer Causes, Risk Factors, and Prevention

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression.

Case Based Learning Program

Case 1 PLEASE TURN OFF YOUR CELL PHONES 3/28/2017. Disclosure of Relevant Financial Relationships. Disclosure of Relevant Financial Relationships

Certificate of Advanced Studies in Personalized Molecular Oncology

Molecular and Cell Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester Biomedical Sciences OT 4 0

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Molecular and Cell Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester Biomedical Sciences OT 4 0

Royal Brompton and Harefield Hospitals Clinical Fellowship Programme

IS THROAT CANCER HEREDITARY

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance

oncogenes-and- tumour-suppressor-genes)

Molecular Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester

Case Report Bilateral Renal Tumour as Indicator for Birt-Hogg-Dubé Syndrome

Genetic Predisposition to Cancer

MSc CANCER CELL AND MOLECULAR BIOLOGY (2008/9)

Genetic Testing of Inherited Cancer Predisposition Genetic Testing - Oncology

Mainstreaming Cancer Genetics (MCG) Information Pack

Clinical Cancer Genetics

Molecular Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath)

Renal tumours: use of immunohistochemistry & molecular pathology. Dr Lisa Browning John Radcliffe Hospital Oxford

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

SINGAPORE SCIENTISTS DISCOVER NEW PATHWAYS LEADING TO CANCER PROGRESSION

Section D: The Molecular Biology of Cancer

Identification of a novel duplication mutation in the VHL gene in a large Chinese family with Von Hippel-Lindau (VHL) syndrome

Dr Graeme Suthers: The genetic basis of cancer

Cabozantinib for medullary thyroid cancer. February 2012

Lecture 1: Carcinogenesis

School of Health Sciences. School of Health Sciences Psychology.

Developing effective ctdna testing services for lung cancer. Executive summary

Chapter 4 Cellular Oncogenes ~ 4.6 -

Human Genetics 542 Winter 2018 Syllabus

Learning Outcomes: The following list provides the learning objectives that will be covered in the lectures, and tutorials of each week:

Frequently asked questions Deaf Education Postgraduate Diploma / MEd

How does histology alter treatment? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy

Human Genetics 542 Winter 2017 Syllabus

TRAINING IN PSYCHOANALYTIC PSYCHOTHERAPY

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

An information leaflet for patients and families. Von Hippel- Lindau Disease

Your Health Topic : Genomics and Clinical Practice How genetics is improving care for patients

Student Guide To Ethics Review For Research Involving Human Subjects

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

CLINICAL GENETICS 1. GENERAL ASPECTS OF THE SPECIALISATION. 1.1 Purpose of the specialisation

ALBERTA PRINCIPAL INVESTIGATORS

RCSI PHYSIOTHERAPY AT A GLANCE RCSI DEVELOPING HEALTHCARE LEADERS WHO MAKE A DIFFERENCE WORLDWIDE

Session 4 Rebecca Poulos

Information for You and Your Family

What s New in Pathology of Genitourinary Tumors. Jiaoti Huang, MD, PhD Department of Pathology Duke University School of Medicine

BIT 120. Copy of Cancer/HIV Lecture

MODULE SPECIFICATION. Part 1: Basic Data. Module Title Autism Spectrum and Communication Skills Module Code UTTGT Level 2 Version 1

TAKE A NEW LOOK AT ACUPUNCTURE

Developing New Therapies to Treat Glioblastoma

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Advances in the Multidisciplinary Management of Hepatocellular Carcinoma: Strategies for Incorporating Emerging Immunotherapy Treatment Options

MSc Criminology with Forensic Psychology

Diploma in Implant Dentistry Opportunities 2014

Professional Doctorate in Counselling Psychology

APPI HEALTH GROUP - EDUCATION LTD

Session 4 Rebecca Poulos

OMICS Journals are welcoming Submissions

TARGETED THERAPY FOR LUNG CANCER. Patient and Caregiver Guide

Institution : College of Dental Medicine Academic Department : Restorative Dentistry Programme : Course :

Development of Carcinoma Pathways

Cancer and Tyrosine Kinase Inhibition

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

Test Name Results Units Bio. Ref. Interval. Positive

Trust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme

The Leading Global Provider of Fitness & Wellness Education

Translational Neuroscience

Introduction to Genetics

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009

British Psychological Society. 3 years full-time 4 years full-time with placement. Psychology. July 2017

Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

Programme Specification

Renal Cancer. By Jamie Calderwood

2018 Attachment & Trauma Conference

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Course Curriculum for Master Degree in Medical Laboratory Sciences / Diagnostic Molecular Biology and Human Genetics

Pailin Group Executive Search Assistant Investigator: Cancer Genetics, Epigenetics and Biomarkers Dallas, TX

Faculty of Social Sciences

PEDIATRIC OTOLARYNGOLOGY FELLOWSHIP. B.C. Children s Hospital University of British Columbia Vancouver, B.C.

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

Backgrounder. 1. What are targeted therapies? 2. How do targeted therapies work?

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

TITLE OF MODULE: Epigenetics in Development and Disease

Therapy-related acute myeloid leukemia with germline TP53 mutation (Li-Fraumeni syndrome) SH Chelsey Deel MD Teresa Scordino MD

Peninsula School of Dentistry. Programme Specification. MSc Minor Oral Surgery (Part Time) (4644)

Cell Cycle and Cancer

NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015

A S p e c i a l I n v i t a t i o n

Transcription:

In-depth courses from HSTalks CANCER GENETICS The Biomedical & Life Sciences Collection A complete advanced undergraduate/graduate course with: 16 online lectures by leading authorities Resources for workshops, tutorials, journal clubs, projects and seminars Suggested exam questions and model answers Multiple choice questions and answers Recommended reading: original papers and review articles View the content of the course on our website: hstalks.com/cancergenetics www.hstalks.com/cancergenetics View our in-depth HSTalks: www.hstalks.com/coursesbrochure

Course module with video lectures, material for tutorials (case studies, projects, workshops and recommended reading), multiple choice questions and suggested exam questions with model answers. A comprehensive course on a subject of major importance. The material is especially designed to support research and teaching staff when presenting a comprehensive course at graduate or advanced undergraduate level with seminars, journal clubs, laboratory exercises, data workshops, online tests and end of course examinations. The course is also suitable for continuing professional development/education programmes. This brochure provides brief details of the complete module, including the lectures, lecturers and additional learning material. Who is the course for? The comprehensive material is especially suitable for teachers and researchers who wish to offer courses on specialist subjects to small groups of students (or even a single student) when it is not possible to justify the time and expense of preparing, internally, a course or there is not the range of expertise available locally to do so. All the lecturers are highly regarded experts in their fields and few institutions are likely to have a comprehensive group of faculty members with a similar range of experience and knowledge of the subject matter. The course material is designed to be used by local faculty and staff acting as course directors, tutors and mentors. The material is suitable for flipped classroom, blended, team and distance learning courses. New courses are time consuming and expensive to create. These modules cut both the cost and the time, enabling a wider range of options to be offered on specialist topics. Graduate students can take the courses, mentored by their supervisors, while pursuing their research. Ideal for Virtual Learning Environments (VLE) All course material, including the additional learning material, is arranged in a standard format that allows easy embedding into virtual learning environments such as Moodle, Blackboard or your institute s own system. Supporting learning and teaching goals In an age when faculty and staff face ever greater demands on budgets and time, these lectures and additional learning material will be of great help when preparing and delivering graduate and advanced undergraduate courses. 2 CANCER GENETICS

Course Summary Cancer is a genetic disease because it is caused by mutations. Cancer Genetics is the discipline of understanding the genetic processes underlying tumor development. Genetics play a unique role in the laboratory and in the clinic in understanding the mechanisms of transformation of a normal cell to cancer, prediction of the risk of developing cancer, early detection, prevention, prognosis and therapy. Nearly all cancers arise from a single cell harboring a combination of inherited and/or somatic alterations in genetic material. Once initiated, cancer cells continuously evolve by acquiring additional and complex mutations in the genetic material leading to uncontrolled cell proliferation (cell cycle deregulation) and spreading to other organs (metastasis). The complexity of genetic aberrations includes changes in chromosome number and structure, single nucleotide changes, DNA methylation and modifications in non-coding RNA, among many others. These mutations affect protein coding genes, noncoding DNA and epigenetic modifications. In the recent decades we have witnessed dramatic developments in the technologies available for analyzing genomes. Recent advances in genomic technologies and bioinformatics are providing crucial tools to understand the role of genetics in mechanisms of transformation, progression, and metastasis of cancer cells. These advances are paving ways to achieve the goal of personalized treatment of cancer. The course on Cancer Genetics will address most of these cutting-edge developments in cancer biology. Editor: Prof. Vundavalli Murty Columbia University Medical Center, USA The course module is designed for: This course is of interest to a wide variety of audiences including life-science students at graduate and postgraduate level, researchers studying the genetics of cancer, and clinicians involved with oncology. 3 CANCER GENETICS

Course Lectures Click the lecture title to access Genetics www.hstalks.com/t/3230/genetics-and-management-of-inherited-cancer-predis/?biosci and management of inherited cancer predisposition Prof. Joshua Schiffman University of Utah, USA The www.hstalks.com/t/3281/the-cytogenetics-of-childhood-acute-leukemia/?biosci cytogenetics of childhood acute leukemia Dr. Susana Raimondi St. Jude Children s Research Hospital, USA Chromosome www.hstalks.com/t/3130/chromosome-translocations-and-cancer/?biosci translocations and cancer Prof. Felix Mitelman Lund University, Sweden Acute www.hstalks.com/t/3197/genetics-of-acute-myeloid-leukemia/?biosci myeloid leukemia: genetics, prognosis and treatments Prof. Stephen Nimer University of Miami Health Care, USA Genetic www.hstalks.com/t/3138/genetic-abnormalities-in-acute-lymphoblastic-leuke/?biosci abnormalities in acute lymphoblastic leukemia Prof. Ching Hon Pui St. Jude Children s Hospital, USA www.hstalks.com/t/3143/molecular-genetics-of-non-hodgkin-lymphoma/?biosci Molecular of non-hodgkin lymphoma Prof. Jude Fitzgibbon University of London, UK www.hstalks.com/t/3137/genetics-of-breast-and-ovarian-cancer/?biosci Genetics of and ovarian cancer Prof. Jeffrey Weitzel City of Hope, USA The www.hstalks.com/t/3142/the-genetics-and-genomics-of-familial-renal-carcin/?biosci and genomics of familial carcinoma Prof. Eamonn Maher University of Cambridge, UK 4 CANCER GENETICS

16 specially recorded, animated lectures by world leading authorities Click the lecture title to access www.hstalks.com/t/3196/genomics-of-lung-cancer/?biosci Genomics of lung cancer Prof. Ramaswamy Govindan Washington University in St. Louis, USA The www.hstalks.com/t/3192/the-genetics-of-glioblastoma/?biosci of glioblastoma Dr. Hai Yan Duke University School of Medicine, USA Genetics www.hstalks.com/t/3136/genetics-of-tumor-metastasis-1/?biosci of tumor metastasis Prof. Robert Weinberg Whitehead Institute for Biomedical Research, USA CML: www.hstalks.com/t/3131/cml-genetic-paradigm-of-targeted-therapy-1/?biosci of targeted therapy Prof. Michael W. Deininger University of Utah, USA The www.hstalks.com/t/3140/the-non-coding-rna-revolution-in-the-cancer-societ/?biosci RNA revolution the cancer society Dr. George Calin MD Anderson Cancer Center, USA www.hstalks.com/t/3129/role-of-molecular-markers-in-guiding-therapy-in-ca/?biosci Role of molecular markers therapy cancer Prof. Joe Duffy St Vincent's University Hospital and University College Dublin, Ireland Functional www.hstalks.com/t/3141/functional-cancer-genomics/?biosci cancer Prof. Roderick Beijersbergen Netherlands Cancer Institute, The Netherlands www.hstalks.com/t/3139/pharmacogenomics-in-cancer-therapy/?biosci Pharmacogenomics in cancer therapy Prof. Sharon Marsh University of Alberta, Canada 5 CANCER GENETICS

Examples of Course Materials For each lecture the course offers tutorials, workshops, recommended reading, multiple-choice questions, and suggested exam questions with model answers. HST Moodle My Courses Cancer Genetics Tutorial: The genetics and genomics of familial renal carcinoma Lecturer: Prof. Eamonn Maher University of Cambridge, UK Patient X has been diagnosed with renal cell carcinoma (RCC) and subsequently treated with a total nephrectomy. The following year the patient approaches the genetics clinic as they become concerned that their healthy 9 year old child might also be at risk of this type of cancer. a) What factors in the medical history would indicate a greater likelihood of an inherited cause? b) Genetic testing is carried out using a gene panel, revealing a mutation in FH and providing a diagnosis of Hereditary Leiomyomatosis with Renal Cell Carcinoma (HLRCC). What are some of the advantages and disadvantages of gene panel testing in RCC. c) How might this patient s children be managed in light of their parent s diagnosis and what are some of the difficulties with these recommendations?? Exam Questions and Model Answers Question 1 Not yet answered Marked out of 1.00 Hereditary papillary renal cell carcinoma type 1 is a rare condition caused by constitutional mutations in the MET gene. What characterizes this condition from a molecular perspective and how does this impact on management? A A B I 1 2 3 Flag question Edit question Multiple-choice questions and answers Question 4 Not yet answered Marked out of 1.00 Flag question Edit question Which of the following is not a recognized cause of inherited renal cell carcinoma? Select one: a) Birt Hogg Dube syndrome b) Constitutional SDHD mutation c) Von-Hippel Lindau disease d) Constitutional BAP1 mutation e) Lynch syndrome Recommended reading supporting each lecture: Original research papers and review articles 1. Eng, C. (2008). SDHB - A gene for all tumors? Journal of the National Cancer Institute, 100(17), 1193-1195. 2. Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Staehler, M., Bukowski, R. M. (2009). Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. Journal of Clinical Oncology, 27(20), 3312-3318. 3. Maher, E. R. (2011). Genetics of familial renal cancers. Nephron. Experimental Nephrology, 118(1), e21-6. 4. Maher, E. R., Neumann, H. P., & Richard, S. (2011). von Hippel-Lindau disease: a clinical and scientific review. European Journal of Human Genetics: EJHG, 19(6), 617-23. 5. Menko, F. H., Maher, E. R., Schmidt, L. S., Middelton, L. a., Aittomäki, K., Tomlinson, I., Linehan, W. M. (2014). Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Familial Cancer, 637-644. 6. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Zbar, B. (1997). Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genetics, 16(1), 68-73. 6 CANCER GENETICS

How to access the course Extracts of lectures can be viewed at hstalks.com/biosci/. The full length lectures can be viewed by all members of universities, colleges and medical schools currently subscribing to The Biomedical & Life Sciences Collection. Institutions that do not subscribe to The Biomedical & Life Sciences Collection may take annual licenses at US $2,000 covering an unlimited number of students. Full supporting material: video lectures, material for tutorials (case studies, projects, workshops and recommended reading), multiple choice questions and suggested exam questions with model answers are provided to faculty members of subscribers. To subscribe, obtain additional information and/or the additional learning material contact Dr. Eyal Kalie at eyalk@hstalks.com. Upload to your VLE The complete course (lectures and additional learning material) can be loaded into Moodle, Blackboard and other virtual learning environments. 7 CANCER GENETICS

HSTalks provides access to world class lectures by leading authorities from around the globe, in one online resource. Our subscribers include a wide range of universities, medical schools, colleges, hospitals, government agencies and pharmaceutical companies. www.hstalks.com Email: sales@hstalks.com Tel: +44 207 164 6721 Corporate Headquarters Henry Stewart Talks Ltd. Russell House 28-30 Little Russell Street London WC1A 2HN, United Kingdom Company Registration Number: 04833828 (England and Wales) To download a copy of this brochure, visit: hstalks.com/cg www.hstalks.com/cg